ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 62 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,111 | -2.4% | 138,971 | +10.5% | 0.00% | – |
| Q2 2023 | $289,181 | +126.1% | 125,731 | +197.9% | 0.00% | – |
| Q1 2023 | $127,890 | +30.0% | 42,208 | 0.0% | 0.00% | – |
| Q4 2022 | $98,345 | +22.0% | 42,208 | 0.0% | 0.00% | – |
| Q3 2022 | $80,617 | -29.3% | 42,208 | 0.0% | 0.00% | – |
| Q2 2022 | $114,000 | +23.9% | 42,208 | +36.4% | 0.00% | – |
| Q1 2022 | $92,000 | -23.3% | 30,937 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | -12.4% | 30,937 | -2.8% | 0.00% | – |
| Q3 2021 | $137,000 | +42.7% | 31,842 | 0.0% | 0.00% | – |
| Q2 2021 | $96,000 | +100.0% | 31,842 | +137.6% | 0.00% | – |
| Q1 2019 | $48,000 | -5.9% | 13,404 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -59.8% | 13,404 | 0.0% | 0.00% | – |
| Q3 2018 | $127,000 | +29.6% | 13,404 | 0.0% | 0.00% | – |
| Q2 2018 | $98,000 | – | 13,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |